Studies on the potency of various antitussive agents
- PMID: 596317
- DOI: 10.1007/BF01969565
Studies on the potency of various antitussive agents
Abstract
Several antitussive agents were assessed for their cough-suppressant activity. Cough responses were obtained by electrically stimulating the lower brainstem, in cats lightly anesthetized with sodium pentobarbital or in unanesthetized midcollicular decerebrate preparations. Cough sounds were recorded with the aid of a microphone. The cough reactive region was concentrated in an area dorsomedial to the trigeminal tract and nucleus. The potency of these antitussive agents (dextromethorphan, RO 21-4790-001, codeine, clonazepam, diazepam and caramiphen) were determined by studying their effect on the centrally induced cough responses. Each of these agents was administered in graded doses intravenously to determine the minimal effective doses for suppressing the cough responses. They are 0.57, 2.55, 1.71, 0.048, 0.28 and 3.18 mg/kg for the above listed drugs. The results indicate that clonazepam was found to be the most potent antitussive among these agents, the mean effective dose being about 1/35 of that of codeine. The antitussive potency of benzodiazepines is not well correlated with their muscle relaxant activity. For instance, clonazepam and diazepam have the same potency in depressing polysynaptic spinal reflexes, whereas the former is six times more potent than diazepam as an antitussive. This finding indicates that clonazepam has a high specificity as an antitussive.
Similar articles
-
Studies on the localization of central cough mechanism; site of action of antitussive drugs.J Pharmacol Exp Ther. 1975 Sep;194(3):499-505. J Pharmacol Exp Ther. 1975. PMID: 1159627
-
Evidence for a central site of action for the antitussive effects of caramiphen.J Pharmacol Exp Ther. 1985 Apr;233(1):249-53. J Pharmacol Exp Ther. 1985. PMID: 3981459
-
A new method for evaluating antitussives in cats using an electrode-cannula.Eur J Pharmacol. 1975 Nov;34(1):59-63. doi: 10.1016/0014-2999(75)90225-3. Eur J Pharmacol. 1975. PMID: 1234769
-
Codeine and its alternates for pain and cough relief. 3. The antitussive action of codeine--mechanism, methodology and evaluation.Bull World Health Organ. 1969;40(3):425-54. Bull World Health Organ. 1969. PMID: 4896168 Free PMC article. Review.
-
Where are the new cough treatments: a debriefing of recent clinical proof-of-concept trials with the NOP agonist SCH 486757.Pharmacology. 2011;88(1-2):50-4. doi: 10.1159/000328782. Epub 2011 Jul 15. Pharmacology. 2011. PMID: 21757975 Review.
Cited by
-
Dextromethorphan differentially affects opioid antinociception in rats.Br J Pharmacol. 2005 Feb;144(3):400-4. doi: 10.1038/sj.bjp.0706086. Br J Pharmacol. 2005. PMID: 15655510 Free PMC article.
-
Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan.J Neuroimmune Pharmacol. 2012 Sep;7(3):656-64. doi: 10.1007/s11481-012-9382-z. Epub 2012 Jun 23. J Neuroimmune Pharmacol. 2012. PMID: 22730040 Free PMC article. Clinical Trial.
-
Effects of dextromethorphan and oxycodone on treatment of neuropathic pain in mice.J Biomed Sci. 2015 Sep 22;22(1):81. doi: 10.1186/s12929-015-0186-3. J Biomed Sci. 2015. PMID: 26391752 Free PMC article.
-
Central mechanisms II: pharmacology of brainstem pathways.Handb Exp Pharmacol. 2009;(187):203-17. doi: 10.1007/978-3-540-79842-2_10. Handb Exp Pharmacol. 2009. PMID: 18825342 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous